These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer. Zong H; Zhang Y; You Y; Cai T; Wang Y Med Oncol; 2015 Mar; 32(3):85. PubMed ID: 25701462 [TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. Dufort FJ; Gumina MR; Ta NL; Tao Y; Heyse SA; Scott DA; Richardson AD; Seyfried TN; Chiles TC J Biol Chem; 2014 Mar; 289(10):7011-7024. PubMed ID: 24469453 [TBL] [Abstract][Full Text] [Related]
5. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms. Zaidi N; Royaux I; Swinnen JV; Smans K Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913 [TBL] [Abstract][Full Text] [Related]
7. Dual-tracer positron emission tomography/computed tomography as an imaging probe of Tsao CH; Jhou RH; Ke CC; Chang CW; Chang CW; Yang BH; Huang WS; Shih BF; Liu RS Front Med (Lausanne); 2022; 9():1008200. PubMed ID: 36237546 [TBL] [Abstract][Full Text] [Related]
8. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Migita T; Narita T; Nomura K; Miyagi E; Inazuka F; Matsuura M; Ushijima M; Mashima T; Seimiya H; Satoh Y; Okumura S; Nakagawa K; Ishikawa Y Cancer Res; 2008 Oct; 68(20):8547-54. PubMed ID: 18922930 [TBL] [Abstract][Full Text] [Related]
9. ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury. Li R; Meng M; Chen Y; Pan T; Li Y; Deng Y; Zhang R; Tian R; Xu W; Zheng X; Gong F; Liu J; Tang H; Ding X; Tang Y; Annane D; Chen E; Qu H; Li L Cell Death Dis; 2023 Jul; 14(7):401. PubMed ID: 37414769 [TBL] [Abstract][Full Text] [Related]
10. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis. Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164 [TBL] [Abstract][Full Text] [Related]
11. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism. Granchi C Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238 [TBL] [Abstract][Full Text] [Related]
12. ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage. Chakraborty A; Dorsett KA; Trummell HQ; Yang ES; Oliver PG; Bonner JA; Buchsbaum DJ; Bellis SL J Biol Chem; 2018 Jan; 293(3):984-994. PubMed ID: 29191829 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells. Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723 [TBL] [Abstract][Full Text] [Related]
14. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934 [TBL] [Abstract][Full Text] [Related]
15. Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition. Li X; Roife D; Kang Y; Dai B; Pratt M; Fleming JB Oncogene; 2016 Sep; 35(37):4881-90. PubMed ID: 26876211 [TBL] [Abstract][Full Text] [Related]
16. Up-regulation of fatty acid synthase induced by EGFR/ERK activation promotes tumor growth in pancreatic cancer. Bian Y; Yu Y; Wang S; Li L Biochem Biophys Res Commun; 2015 Aug; 463(4):612-7. PubMed ID: 26043686 [TBL] [Abstract][Full Text] [Related]
17. LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma. Okada Y; Takahashi N; Takayama T; Goel A Carcinogenesis; 2021 Apr; 42(4):546-556. PubMed ID: 33624791 [TBL] [Abstract][Full Text] [Related]
18. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621 [TBL] [Abstract][Full Text] [Related]
19. ATP citrate lyase mediates resistance of colorectal cancer cells to SN38. Zhou Y; Bollu LR; Tozzi F; Ye X; Bhattacharya R; Gao G; Dupre E; Xia L; Lu J; Fan F; Bellister S; Ellis LM; Weihua Z Mol Cancer Ther; 2013 Dec; 12(12):2782-91. PubMed ID: 24132143 [TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. Maftouh M; Avan A; Sciarrillo R; Granchi C; Leon LG; Rani R; Funel N; Smid K; Honeywell R; Boggi U; Minutolo F; Peters GJ; Giovannetti E Br J Cancer; 2014 Jan; 110(1):172-82. PubMed ID: 24178759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]